InvestorsHub Logo
Followers 572
Posts 9510
Boards Moderated 1
Alias Born 09/03/2004

Re: None

Tuesday, 07/25/2017 2:16:51 PM

Tuesday, July 25, 2017 2:16:51 PM

Post# of 49606
RJDG and TLTFF

RJDG a penny stock with earnings and huge prospects for growth in software services for healthcare.

TLTFF - announced the 90 day results after treatment for bladder cancer with Photo Dynamic Compound actuated by controlled/cell sensitized cold laser. These three patients had failed all other treatments and left with bladder removal/resection as an option. 90 day trial early results indicates no detectable cancer in two patients and one has red spots that will be biopsied. All this from a treatment that has no side affects and could be repeated if necessary. Meanwhile it is important to realize that bladder cancer has an 80% recurrence rate and the US alone is a $4 Billion market. Trading at 35 cents and somewhat over 200 million OS. Next step is 6 patients considered to have exhausted all other options with 6 month follow up and then 26 location trials world wide have been projected.

Read the TLT Canadian news today or Investors Hub repost at TLTFF.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.